The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDalata Hotel Gp Regulatory News (DAL)

Share Price Information for Dalata Hotel Gp (DAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 56.00 (16.97%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 358.00
DAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dalata Hotel Group PLC: Purchase of new London Hotel

16 Feb 2023 07:00

Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: Purchase of new London Hotel 16-Feb-2023 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


 

Dalata Hotel Group announces purchase of new London hotel for £44.3 million

The Group’s first Maldron Hotel in London

 

ISE: DHG              LSE: DAL

Dublin and London | 16 February 2023: Dalata Hotel Group plc ("Dalata" or "the Group"), the largest hotel operator in Ireland, with a growing presence in the United Kingdom and continental Europe, is pleased to announce the addition of a new 192-bedroom hotel at 240 Seven Sisters Road, Finsbury Park, North London to its hotel portfolio. Under the transaction, Dalata has acquired the entire issued share capital of Tide Developments (4) Limited (“TD4”) for a total consideration of £44.3 million (€49.7 million) from Furadino Holdings Limited. TD4 has a gross asset value of £45.1 million and owns the freehold interest of the hotel property. The total consideration will be financed from Dalata’s existing cash and banking facilities.

The newly finished hotel, which has never traded, consists of 192 bedrooms, ground floor lobby and a restaurant and bar. Prior to opening in summer 2023, Dalata will invest in excess of £2 million to enhance the property and launch under the Maldron brand. The hotel, with an expectation of stabilised annual earnings of £4 million, will be Dalata’s first Maldron hotel in London, its 18th hotel in the UK and will create over 50 jobs locally. Conveniently located within walking distance of the Emirates Stadium, the hotel is adjacent to Finsbury Park Station, with extensive National Rail, London Underground and bus services offering direct links to King’s Cross St Pancras and the centre of London.

The property was constructed using the Vision Modular System, which can result in as much as a 40 per cent saving in the embodied carbon emissions when compared with traditional methods of construction. The sustainably designed hotel is BER A rated, includes photovoltaic panels, and is expected to achieve BREEAM ‘Excellent’ accreditation.

Dermot Crowley, CEO, Dalata commented on the announcement:

“London is a key strategic growth market for Dalata. We are very excited to be opening our first Maldron hotel in the city in advance of our Maldron in Shoreditch which is currently under construction. This acquisition represents an outstanding opportunity to operate a new, sustainably built, hotel in a vibrant and developing area as we continue our ambitious UK expansion plan. The strength of our balance sheet has been a crucial element in enabling us to make this investment as we continue to create value for all of our stakeholders.”

Shane Casserly, Corporate Development Director, Dalata added:

“Acquiring a new hotel asset in London, in challenging funding markets, that will be operational in the summer of 2023, is a fantastic achievement by the Group. This transaction highlights our appetite for growth as well as the flexibility of our business model, which enables us to grow through acquisition, development and leasing. We are excited by the excellent sustainability credentials of the property as we continue to make progress on our ambitious targets.”

ENDS

 

About Dalata

Dalata Hotel Group plc was founded in August 2007, listed as a plc in March 2014 and is now Ireland’s largest hotel operator, with a growing presence in the UK and continental Europe. The Group operates two primary hotel brands, Clayton Hotels and Maldron Hotels. The Group’s portfolio comprises 50 primarily 4-star hotels situated in city-centre locations with over 10,950 rooms across 29 owned hotels, 18 leased hotels and three management contracts. The Group has ambitious expansion plans for the UK and continental Europe with a committed pipeline of over 1,300 rooms. For the first six months of 2022, Dalata reported revenue of €220.2 million and a profit after tax of €46.7 million. Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL). For further information visit: www.dalatahotelgroup.com

 

Contacts

Dalata Hotel Group plc

Tel +353 1 206 9400

Dermot Crowley, CEO

investorrelations@dalatahotelgroup.com

Shane Casserly, Corporate Development Director

Carol Phelan, CFO

 Graham White, Head of Investor Relations

 

Joint Company Brokers

 

Davy: Anthony Farrell

Tel +353 1 679 6363

Berenberg: Ben Wright

Tel +44 20 3753 3069

 

 

Investor Relations and PR | FTI Consulting

Tel +353 86 401 5250

Melanie Farrell

dalata@fticonsulting.com

 

__________________________

 

 


ISIN:IE00BJMZDW83, IE00BJMZDW83
Category Code:ACQ
TIDM:DAL,DHG
LEI Code:635400L2CWET7ONOBJ04
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:223503
EQS News ID:1561077
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
11th Apr 20177:00 amRNSMain Securities Market Notice
10th Apr 20172:30 pmRNSBlock Listing Application
5th Apr 20179:06 amRNSHolding(s) in Company
30th Mar 20175:30 pmRNSPublication of Annual Report and Notice of AGM
13th Mar 20177:44 amRNSHolding(s) in Company
8th Mar 20177:39 amRNSHolding(s) in Company
6th Mar 20178:13 amRNSHolding(s) in Company
28th Feb 20177:00 amRNS2016 Preliminary Financial Results
14th Feb 20171:55 pmRNSHolding(s) in Company
6th Feb 20177:00 amRNSAppointment of Joint Broker
1st Feb 20174:22 pmRNSHolding(s) in Company
30th Jan 20173:49 pmRNSHolding(s) in Company
13th Jan 20173:56 pmRNSNotice of Results
21st Dec 20169:48 amRNSYear-end Trading Update
19th Dec 201612:12 pmRNSHolding(s) in Company
19th Dec 201612:06 pmRNSHolding(s) in Company
7th Dec 20164:06 pmRNSHolding(s) in Company
22nd Nov 20164:18 pmRNSAcquisition Update
17th Nov 20167:00 amRNSAgreement to Lease Newcastle Hotel
11th Nov 20163:30 pmRNSDirector/PDMR Shareholding
2nd Nov 20165:40 pmRNSAcquisition Update
26th Oct 20167:00 amRNSAcquisition
14th Oct 20164:52 pmRNSHolding(s) in Company
14th Oct 20164:51 pmRNSHolding(s) in Company
14th Oct 20164:49 pmRNSDirector/PDMR Shareholding
14th Oct 20164:47 pmRNSDirector/PDMR Shareholding
14th Oct 20164:46 pmRNSDirector/PDMR Shareholding
13th Oct 20164:51 pmRNSHolding(s) in Company
13th Oct 20164:50 pmRNSHolding(s) in Company
7th Oct 201610:55 amRNSDirector/PDMR Shareholding
6th Oct 20169:53 amRNSDirector/PDMR Shareholding
30th Sep 201612:05 pmRNSAcquisition
15th Sep 20165:42 pmRNSHolding(s) in Company
15th Sep 201610:34 amRNSHolding(s) in Company
6th Sep 20167:00 amRNSHalf Yearly Report
25th Aug 20165:16 pmRNSHolding(s) in Company
24th Aug 20167:00 amRNSStatement re: Exclusive Discussions
17th Aug 201612:08 pmRNSNotice of Half Year Results
11th Aug 20166:27 pmRNSHolding(s) in Company
11th Aug 201612:41 pmRNSHolding(s) in Company
4th Aug 201611:48 amRNSHolding(s) in Company
12th Jul 20165:16 pmRNSHolding(s) in Company
7th Jul 201611:03 amRNSHolding(s) in Company
6th Jul 20163:01 pmRNSHolding(s) in Company
6th Jul 20162:59 pmRNSHolding(s) in Company
6th Jul 20162:57 pmRNSHolding(s) in Company
5th Jul 201612:44 pmRNSDisclosure of Home Member State
4th Jul 20164:04 pmRNSHolding(s) in Company
4th Jul 20163:37 pmRNSHolding(s) in Company
30th Jun 20165:14 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.